-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FEQCDhckvvb34PUHxpdaRQt+8SzMi125u4618XrBCGOkhHElin1l+pqAvoMju7uW FZMQeA0hHhqtPQbD2XESCw== 0000914121-00-000059.txt : 20000202 0000914121-00-000059.hdr.sgml : 20000202 ACCESSION NUMBER: 0000914121-00-000059 CONFORMED SUBMISSION TYPE: S-8 POS PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000113 EFFECTIVENESS DATE: 20000113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 POS SEC ACT: SEC FILE NUMBER: 333-92747 FILM NUMBER: 506617 BUSINESS ADDRESS: STREET 1: ONE COPLEY PLACE STREET 2: SUITE 602 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 2124310001 MAIL ADDRESS: STREET 1: ONE COPLEY PLACE, SUITE 602 CITY: BOSTON STATE: MA ZIP: 02116 S-8 POS 1 POST-EFFECTIVE AMENDMENT NO. 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OXiGENE, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 13-3679168 (I.R.S. employer identification no.) One Copley Place, Suite 602, Boston MA 02116 - - ---------------------------------------------------------------------------- (Address of principal executive offices) (Zip code) 1996 Stock Incentive Plan (Full title of the plan) Gerald A. Eppner, Esq. Cadwalader, Wickersham & Taft 100 Maiden Lane New York, NY 10038 (Name and address of agent for service) (212) 504-6000 (Telephone number, including area code, of agent for service) CALCULATION OF REGISTRATION FEE =======================================================================================
Title of Amount Proposed maximum Proposed maximum Amount of securities to be offering price aggregate registration to be registered registered per share(1) offering price(1) fee - - --------------------------------------------------------------------------------------- Common Stock, par value $.01 per share 1,260,419 $28.8125 $18,895,004 $4,989 =======================================================================================
(1) Of the shares being registered, 12,000 shares are being offered at $6.00 per share, 16,000 shares are being offered at $8.50 per share, 186,804 shares are being offered at $8.9375 per share, 8,000 shares are being offered at $9.00 per share, 2,000 shares are being offered at $9.438 per share, 184,431 shares are being offered at $10.00 per share, 58,500 shares are being offered at $10.25 per share, 55,569 shares are being offered at $10.50 per share, 45,000 shares are being offered at $12.00 per share, 30,000 shares are being offered at $22.125 per share, and 100,000 shares are being offered at $28.8125 per share. In addition, 552,115 shares are to be offered at prices not presently determinable. Pursuant to Rule 457(h), the offering price of such 552,115 shares is estimated solely for the purpose of determining the registration fee and is based on the average of the bid and asked prices of the Common Stock (approximately $17.625) quoted on The Nasdaq Stock Market, Inc. National Market on December 9, 1999. POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT (1) The cover page of Exhibit No. 4.2 is hereby amended as follows: "OXiGENE, INC. 1996 STOCK INCENTIVE PLAN (As Amended Through November 12, 1998)" is hereby deleted and replaced to read: "OXiGENE, INC. 1996 STOCK INCENTIVE PLAN (As Amended Through November 12, 1999)". (2) Page 1 of Exhibit No. 4.2 is hereby amended as follows: "OXiGENE, INC. 1996 STOCK INCENTIVE PLAN (As Amended Through October 8, 1998)" is hereby deleted and replaced to read: "OXiGENE, INC. 1996 STOCK INCENTIVE PLAN (As Amended Through November 12, 1999)". No further amendment to the Registrant's Registration Statement on Form S-8 is hereby effected. SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Stockholm, Sweden or in the City of New York, State of New York, on this 13th day of January 2000. OXiGENE, INC. By: /s/ Bjorn Nordenvall ----------------------------- Bjorn Nordenvall President and Chief Executive Officer -----END PRIVACY-ENHANCED MESSAGE-----